StockData
AC Immune SA logo

AC Immune SA (ACIU) stock

ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$2.13+0.03 (+1.43%)

Close on Nov 19, 2026Market cap $216.71MP/E –Yield –

AC Immune free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

AC Immune's free cash flow for the twelve months ending Dec 31, 2022 was -CHF 74.81M. For fiscal 2025 it was -CHF 70.16M, down 207.5% from the year before. The highest annual figure on record is CHF 65.27M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CHF 70.16M-207.5%
FY2024Dec 31, 2024CHF 65.27M–
FY2023Dec 31, 2023-CHF 61.21M–
FY2022Dec 31, 2022-CHF 74.81M–
FY2021Dec 31, 2021-CHF 68.32M–
FY2020Dec 31, 2020-CHF 61.22M-214.8%
FY2019Dec 31, 2019CHF 53.34M–
FY2018Dec 31, 2018-CHF 45.94M–
FY2017Dec 31, 2017-CHF 23.90M–
FY2016Dec 31, 2016-CHF 6.55M-114.9%
FY2015Dec 31, 2015CHF 43.84M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022-CHF 17.45M–
Q3 FY2022Sep 30, 2022-CHF 13.66M–
Q4 FY2021Dec 31, 2021-CHF 18.55M–

More AC Immune figures

See a number that looks wrong?